Cargando…

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer

BACKGROUND: The purpose of this study was to investigate the role of malignant ascites tumor microenvironment in ovarian cancer progression and chemoresistance. METHODS: A total of 45 patients with ovarian cancer and three benign ascites were collected at the time of clinical intervention. Ascites c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Soochi, Lee, Maria, Dhanasekaran, Danny N., Song, Yong Sang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288854/ https://www.ncbi.nlm.nih.gov/pubmed/30526541 http://dx.doi.org/10.1186/s12885-018-5152-5

Ejemplares similares

Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro
por: Kim, Soochi, et al.
Publicado: (2016)

Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2016)

Tumor evolution and chemoresistance in ovarian cancer
por: Kim, Soochi, et al.
Publicado: (2018)

Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
por: Kim, Sungsik, et al.
Publicado: (2018)

Author Correction: Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
por: Kim, Sungsik, et al.
Publicado: (2018)

Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
por: Kim, Boyun, et al.
Publicado: (2017)

ENHO, RXRA, and LXRA polymorphisms and dyslipidaemia, related comorbidities and survival in haemodialysis patients
por: Grzegorzewska, Alicja E., et al.
Publicado: (2018)

PGC1α induced by reactive oxygen species contributes to chemoresistance of ovarian cancer cells
por: Kim, Boyun, et al.
Publicado: (2017)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)

Prostate Cancer Stimulation by a Novel Liver X Receptor (LXRa)-Estrogen Related Receptor (ERRa) Axis
por: Song, Chung Seog, et al.
Publicado: (2021)

Expression of ABCA1 Transporter and LXRA/LXRB Receptors in Placenta of Women with Late Onset Preeclampsia
por: Wolski, Hubert, et al.
Publicado: (2022)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
por: Latifi, Ardian, et al.
Publicado: (2012)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Malignant Ascites Promote Adhesion of Ovarian Cancer Cells to Peritoneal Mesothelium and Fibroblasts
por: Uruski, Paweł, et al.
Publicado: (2021)

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer
por: Zhang, Jie, et al.
Publicado: (2022)

MICU1 drives glycolysis and chemoresistance in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2017)

Ovarian Cancer
por: Song, Yong Sang, et al.
Publicado: (2014)

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites
por: Alshuwaykh, Omar, et al.
Publicado: (2022)

Adipocytes promote ovarian cancer chemoresistance
por: Yang, Jiang, et al.
Publicado: (2019)

The Proangiogenic Capabilities of Malignant Ascites Generated by Aggressive Ovarian Tumors
por: Mikuła-Pietrasik, Justyna, et al.
Publicado: (2017)

Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy
por: Lee, Juwon, et al.
Publicado: (2021)

Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer
por: Eum, Hye Hyeon, et al.
Publicado: (2020)

Emerging treatment options for management of malignant ascites in patients with ovarian cancer
por: Eskander, Ramez N, et al.
Publicado: (2012)

Malignant ascites: a source of therapeutic protein against ovarian cancer?
por: Ribaux, Pascale, et al.
Publicado: (2019)

Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
por: Li, Zhang, et al.
Publicado: (2021)

Epigenetic Therapies as a Promising Strategy for Overcoming Chemoresistance in Epithelial Ovarian Cancer
por: Suh, Dong Hoon, et al.
Publicado: (2013)

GNAi2/gip2-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer
por: Ha, Ji Hee, et al.
Publicado: (2021)

Identification of GNA12-driven gene signatures and key signaling networks in ovarian cancer
por: Ha, Ji-Hee, et al.
Publicado: (2021)

TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma
por: Staumont, Bernard, et al.
Publicado: (2020)

The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance
por: Isidoro, Ciro, et al.
Publicado: (2016)

Tumor evolution and intratumor heterogeneity of an epithelial ovarian cancer investigated using next-generation sequencing
por: Lee, Jung-Yun, et al.
Publicado: (2015)

The deubiquitinase USP11 promotes ovarian cancer chemoresistance by stabilizing BIP
por: Zhu, Xiaolin, et al.
Publicado: (2021)

Management of non-ovarian cancer malignant ascites through indwelling catheter drainage
por: Gu, Xiaoli, et al.
Publicado: (2016)

Tumor cell-fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer
por: Han, Qing, et al.
Publicado: (2019)

Chemotherapy sensitivity testing on ovarian cancer cells isolated from malignant ascites
por: den Ouden, Judith E., et al.
Publicado: (2020)

Assessment of cells in the ascitic fluid of women with ovarian hyperstimulation syndrome: the clinical implications for subsequent ovarian malignancy
por: Hatzipetros, Ioannis, et al.
Publicado: (2013)

TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
por: Wang, Ning, et al.
Publicado: (2012)

An Ovarian Steroid Cell Tumor Causing Virilization and Massive Ascites
por: Kim, Young Tae, et al.
Publicado: (2007)

Chemotherapy Promotes Release of Exosomes Which Upregulate Cholesterol Synthesis and Chemoresistance in AML Blasts
por: Hong, Chang-Sook, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcsnnktrc5633kmbbdtt8fa5br